Cisplatin Hikma

Medicinal product

(Invented) name

Cisplatin Hikma

Active substance (s)

Cisplatina

Strength

1 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XA01, Cisplatin

Marketing authorisation holder

UAB Edupharma, Lietuva

Date of authorisation

2025-11-25

Date of renewal

Documents

3032_Cisplatin Hikma_PZ_2025-11-25.docx

3032_Cisplatin Hikma_PIL_2025-11-25.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Cisplatina	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119277	105381	1105381	flakonas	50 ml N1		Receptinis	LT/L/25/3032/001	Netiekiama	-	-	No	-	-	Download
119278	105382	1105382	flakonas	100 ml N1		Receptinis	LT/L/25/3032/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-11-25	Registruotas